Showing results (1241-1250 of 3,496) with videos related to
Sort By:
Pageof 350
Lipids|July 1, 1992
Ascorbate and phenolic antioxidant interactions in prevention of liposomal oxidationC E Thomas, L R McLean, R A Parker, et al.Critical Care Nurse|April 3, 2018
Pressure Injury Development in Patients Treated by Critical Care Air Transport Teams: A Case-Control StudySusan F Dukes, Genny M Maupin, Marilyn E Thomas, et al.Analytical Chemistry|February 5, 2000
Identification of arsenosugars at the picogram level using nanoelectrospray quadrupole time-of-flight mass spectrometryS A Pergantis, S Wangkarn, K A Francesconi, et al.Addictive Behaviors|July 13, 2000
Cognitive behavioral therapy delays relapse in female socially phobic alcoholicsA K Thevos, J S Roberts, S E Thomas, et al.Bioseparation|August 24, 2001
Sub-micron particle manipulation in an ultrasonic standing wave: applications in detection of clinically important biomoleculesM A Sobanski, C R Tucker, N E Thomas, et al.Pediatric Transplantation|June 26, 2001
Comparison of polyclonal induction agents in pediatric renal transplantationP D Brophy, S E Thomas, K D McBryde, et al.Analytical Chemistry|June 7, 2011
Characterization of arsenosugars of biological origin using fast atom bombardment tandem mass spectrometryS A Pergantis, K A Francesconi, W Goessler, et al.Substance Abuse|April 12, 2012
Client attitudes toward alcohol use self-reportSarah W Book, Suzanne E Thomas, Scott H Stewart, et al.Current Drug Safety|November 30, 2011
Reporting rates of yellow fever vaccine 17D or 17DD-associated serious adverse events in pharmacovigilance data bases: systematic reviewRoger E Thomas, Diane L Lorenzetti, Wendy Spragins, et al.The American Journal of Tropical Medicine and Hygiene|February 4, 2012
The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic reviewRoger E Thomas, Diane L Lorenzetti, Wendy Spragins, et al.Pageof 350